托伐普坦-话题@MedSci

#托伐普坦#

12篇内容 | 1106人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2237592, encodeId=0e7c223e59263, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a> <a href='/topic/show?id=ec0d1145e586' target=_blank style='color:#2F92EE;'>#常染色体显性多囊肾病（ADPKD）#</a>, objectTitle=CKJ：托伐普坦治疗常染色体显性多囊肾病的肝脏安全性, objectType=article, longId=851653, objectId=bcd18516533d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241117/1731840202735_5121051.jpg, objectUrl=/article/show_article.do?id=bcd18516533d, replyNumber=0, likeNumber=10, createdTime=2024-11-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bcd18516533d, moduleTitle=CKJ：托伐普坦治疗常染色体显性多囊肾病的肝脏安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcd18516533d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1703832, encodeId=4c5d1e038325b, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=J Gastroenterology：对托伐普坦的持久反应可改善肝硬化的长期生存质量, objectType=article, longId=199977, objectId=93bf1999e730, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93bf1999e730, replyNumber=0, likeNumber=108, createdTime=2021-03-17, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93bf1999e730, moduleTitle=J Gastroenterology：对托伐普坦的持久反应可改善肝硬化的长期生存质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93bf1999e730)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703833, encodeId=0f141e03833eb, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=J Gastroenterology: 肝硬化患者对托伐普坦的持久反应可提高无复发的长期生存率, objectType=article, longId=204151, objectId=d99f20415102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d99f20415102, replyNumber=0, likeNumber=61, createdTime=2021-02-01, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d99f20415102, moduleTitle=J Gastroenterology: 肝硬化患者对托伐普坦的持久反应可提高无复发的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d99f20415102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703830, encodeId=c6031e0383023, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=Nephrol Dial Transplant：常染色体显性多囊肾病患者长期使用托伐普坦怎么样？, objectType=article, longId=134767, objectId=7449134e67c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7449134e67c0, replyNumber=0, likeNumber=75, createdTime=2019-02-13, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7449134e67c0, moduleTitle=Nephrol Dial Transplant：常染色体显性多囊肾病患者长期使用托伐普坦怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7449134e67c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703831, encodeId=bd2d1e038317d, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=BMC Gastroenterology：托伐普坦可改善腹水和低钠血症的肝硬化患者的生存率, objectType=article, longId=148988, objectId=b9141489889b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9141489889b, replyNumber=0, likeNumber=75, createdTime=2019-08-24, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9141489889b, moduleTitle=BMC Gastroenterology：托伐普坦可改善腹水和低钠血症的肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9141489889b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703828, encodeId=3eca1e03828a7, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=J Gastroenterol Hepatol：BUN和尿钠水平与肝硬化肝源性腹水患者对托伐普坦（tolvaptan）的反应密切相关, objectType=article, longId=123370, objectId=93821233e033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93821233e033, replyNumber=0, likeNumber=68, createdTime=2018-02-26, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93821233e033, moduleTitle=J Gastroenterol Hepatol：BUN和尿钠水平与肝硬化肝源性腹水患者对托伐普坦（tolvaptan）的反应密切相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93821233e033)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703829, encodeId=7db01e038298d, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=N Engl J Med：托伐普坦晚期常染色体显性多囊肾病的福音？, objectType=article, longId=124736, objectId=0cec124e3608, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cec124e3608, replyNumber=0, likeNumber=64, createdTime=2018-04-12, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cec124e3608, moduleTitle=N Engl J Med：托伐普坦晚期常染色体显性多囊肾病的福音？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cec124e3608)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703827, encodeId=011b1e0382734, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=NEJM：晚期常染色体显性多囊肾病采用托伐普坦治疗效果分析！, objectType=article, longId=118848, objectId=b4441188489d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4441188489d, replyNumber=0, likeNumber=74, createdTime=2018-03-30, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4441188489d, moduleTitle=NEJM：晚期常染色体显性多囊肾病采用托伐普坦治疗效果分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4441188489d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703826, encodeId=2e761e0382692, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=2015 NICE技术评估指南：托伐普坦治疗常染色体显性遗传性多囊性肾病（TA358）, objectType=article, longId=83669, objectId=e4ee83669a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4ee83669a8, replyNumber=0, likeNumber=68, createdTime=2016-12-31, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4ee83669a8, moduleTitle=2015 NICE技术评估指南：托伐普坦治疗常染色体显性遗传性多囊性肾病（TA358）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4ee83669a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703825, encodeId=71cf1e0382514, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=2015NICE技术评估指南——托伐普坦治疗常染色体显性遗传性多囊肾病（TA358）发布, objectType=article, longId=79985, objectId=153ce9985ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=153ce9985ac, replyNumber=0, likeNumber=64, createdTime=2017-02-05, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=153ce9985ac, moduleTitle=2015NICE技术评估指南——托伐普坦治疗常染色体显性遗传性多囊肾病（TA358）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=153ce9985ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703824, encodeId=dab71e038247f, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=Ann Intern Med：托伐普坦成本效益不具优势, objectType=article, longId=24828, objectId=5d1d2482877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d1d2482877, replyNumber=0, likeNumber=73, createdTime=2013-09-30, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d1d2482877, moduleTitle=Ann Intern Med：托伐普坦成本效益不具优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d1d2482877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703823, encodeId=c7361e03823b8, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=FDA：肝病患者禁用托伐普坦, objectType=article, longId=18026, objectId=5a3d1802621, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a3d1802621, replyNumber=0, likeNumber=75, createdTime=2013-09-03, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a3d1802621, moduleTitle=FDA：肝病患者禁用托伐普坦, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a3d1802621)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703822, encodeId=89811e03822c3, content=<a href='/topic/show?id=990654666b8' target=_blank style='color:#2F92EE;'>#托伐普坦#</a>, objectTitle=日本大冢公司血管加压素受体拮抗剂托伐普坦（苏麦卡）在中国上市, objectType=article, longId=4134, objectId=c16b4134b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c16b4134b8, replyNumber=0, likeNumber=90, createdTime=2012-04-21, rootId=0, userName=yytms, userId=57c130593395, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c16b4134b8, moduleTitle=日本大冢公司血管加压素受体拮抗剂托伐普坦（苏麦卡）在中国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c16b4134b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

托伐普坦

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#托伐普坦# #常染色体显性多囊肾病（ADPKD）#

CKJ：托伐普坦治疗常染色体显性多囊肾病的肝脏安全性

2024-11-18发表于上海

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

J Gastroenterology：对托伐普坦的持久反应可改善肝硬化的长期生存质量

2021-03-17

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

J Gastroenterology: 肝硬化患者对托伐普坦的持久反应可提高无复发的长期生存率

2021-02-01

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

Nephrol Dial Transplant：常染色体显性多囊肾病患者长期使用托伐普坦怎么样？

2019-02-13

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

BMC Gastroenterology：托伐普坦可改善腹水和低钠血症的肝硬化患者的生存率

2019-08-24

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

J Gastroenterol Hepatol：BUN和尿钠水平与肝硬化肝源性腹水患者对托伐普坦（tolvaptan）的反应密切相关

2018-02-26

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

N Engl J Med：托伐普坦晚期常染色体显性多囊肾病的福音？

2018-04-12

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

NEJM：晚期常染色体显性多囊肾病采用托伐普坦治疗效果分析！

2018-03-30

一叶知秋 (审核中...)

前往app查看评论内容

#托伐普坦#

2015 NICE技术评估指南：托伐普坦治疗常染色体显性遗传性多囊性肾病（TA358）

2016-12-31

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

2015NICE技术评估指南——托伐普坦治疗常染色体显性遗传性多囊肾病（TA358）发布

2017-02-05

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

Ann Intern Med：托伐普坦成本效益不具优势

2013-09-30

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

FDA：肝病患者禁用托伐普坦

2013-09-03

yytms (审核中...)

前往app查看评论内容

#托伐普坦#

日本大冢公司血管加压素受体拮抗剂托伐普坦（苏麦卡）在中国上市

2012-04-21

科室
- - 订阅+
  - 更多科室
工具
服务